Briefing: OpenAI acquires popular tech podcast TBPN
Strategic angle: OpenAI did not disclose the terms of the deal but said TBPN will be housed within its strategy organization.
Technology, AI, cybersecurity, infrastructure, and innovation.
Strategic angle: OpenAI did not disclose the terms of the deal but said TBPN will be housed within its strategy organization.
Strategic angle: Join Zep AI in developing innovative solutions for the agent context layer.
Strategic angle: The Information reports on the implications of Anthropic's new AI model for cybersecurity.
Strategic angle: Seeking suggestions for European tech alternatives due to difficulties with existing platforms.
Strategic angle: Explore the latest features and updates in Tailscale's new macOS home.
Strategic angle: A pioneer in technology and BBQ innovation, George Goble has passed away.
Strategic angle: The Justice Department is contesting a ruling that halts the ban on Anthropic's AI technologies.
Strategic angle: Explore the latest features in Hugo that enhance CSS capabilities.
Strategic angle: The latest update on Cursor 3 brings exciting features for developers.
Strategic angle: An analysis of AI-powered devices that received the FDA's 'breakthrough' label.
Strategic angle: GDDRHammer, GeForge and GPUBreach hammer GPU memory in ways that hijack the CPU.
Strategic angle: Researchers at IIAMA develop advanced forecasting system for meteorological droughts.
Strategic angle: Exploring the innovative features of EmDash, a new content management system.
Strategic angle: Discover the latest advancements in AI technology with Gemma 4.
Strategic angle: An autonomous artificial intelligence system accelerates the analysis of electron microscopy images, transforming weeks of work into mere minutes.
Strategic angle: Exploring advancements in AI with Qwen3.6-Plus.
Analysts highlight Alphabet's strong position in the AI market.
Strategic angle: One of the year's most intriguing games was developed using software first released 40 years ago.
Strategic angle: An analysis of AI-powered devices that received FDA's 'breakthrough' label shows a preference for big-picture, multi-problem solutions.
Strategic angle: Exploring the ethical implications of AI autonomy.